- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Protein gene product 9.5 (PGP9.5), also known as Ubiquitin C-terminal hydrolase L1 (UCHL1), is a cytoplasmic protein widely expressed in neurons and strongly associated with neuroendocrine differentiation in tumor tissues. The PGP9.5 Antibody / Neuroendocrine Tumor Marker Antibody (clone rUCHL1/4557) is specifically suited for detection of neuroendocrine tumors, supporting identification of tumor cells that exhibit neuronal or neuroendocrine lineage characteristics.
PGP9.5 Antibody, also referred to as UCHL1 antibody or ubiquitin C-terminal hydrolase L1 antibody, is frequently used as a neuroendocrine tumor marker in pathology-oriented studies. Its expression is observed across a range of neuroendocrine tumors, including those arising from neural crest-derived and neuroectodermal lineages. This makes it particularly valuable for distinguishing neuroendocrine tumors from non-neuroendocrine malignancies and for evaluating tumor differentiation status within heterogeneous cancer samples.
This recombinant mouse monoclonal PGP9.5 Antibody (clone rUCHL1/4557) enables clear cytoplasmic detection of UCHL1 in tumor cells, supporting visualization of neuroendocrine tumor cell populations within complex tissue environments. The staining pattern helps define tumor cell distribution and highlights regions of neuroendocrine differentiation, which is critical for tumor classification and comparative analysis across samples.
PGP9.5 expression is closely linked to neuroendocrine tumor biology, where it reflects differentiation toward neuronal or neuroendocrine phenotypes. Its detection is commonly integrated into multi-marker panels used to characterize neuroendocrine tumors and assess lineage identity. The ability to detect UCHL1 alongside other tumor markers enhances interpretation of tumor subtype, cellular origin, and biological behavior in research settings.
A PGP9.5 Antibody / Neuroendocrine Tumor Marker Antibody (clone rUCHL1/4557) is ideally suited for studies focused on neuroendocrine tumors, tumor differentiation analysis, and pathology-based tumor profiling. Its strong positioning as a neuroendocrine tumor marker clearly differentiates it from general neuronal antibodies and supports targeted investigation of neuroendocrine cancer biology.
Optimal dilution of the PGP9.5 Antibody / Neuroendocrine Tumor Marker Antibody should be determined by the researcher.
Recombinant full-length human protein was used as the immunogen for the PGP9.5 Antibody / Neuroendocrine Tumor Marker Antibody.
Store the recombinant PGP9.5 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
UCHL1 antibody, PGP9.5 antibody, Ubiquitin C-terminal hydrolase L1 antibody, Neuroendocrine marker PGP9.5 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.